Get started
Author

Kévin Baranger

Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family
2007 · Thierry Moreau, Kévin Baranger, et al. · Biochimie · 203
Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer’s disease
2014 · Véréna Landel, Kévin Baranger, et al. · Molecular Neurodegeneration · 182
PDF
Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer’s Disease
2018 · Maria Morello, Véréna Landel, et al. · Molecular Neurobiology · 163
PDF
Cerebrovascular pathology during the progression of experimental Alzheimer's disease
2016 · Patrizia Giannoni, Margarita Arango-Lievano, et al. · Neurobiology of Disease · 153
MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease
2015 · Kévin Baranger, Yannick Marchalant, et al. · Cellular and Molecular Life Sciences · 139
PDF
APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-κB activation
2022 · Laurie Arnaud, Philippe Benech, et al. · Cell Reports · 131
PDF
Onset of hippocampus‐dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer's disease
2014 · Stéphane D. Girard, Marlyse Jacquet, et al. · Hippocampus · 128
Area-Specific Alterations of Synaptic Plasticity in the 5XFAD Mouse Model of Alzheimer’s Disease: Dissociation between Somatosensory Cortex and Hippocampus
2013 · Nadine Crouzin, Kevin Baranger, et al. · PLoS ONE · 118
PDF
Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders
2019 · Santiago Rivera, Laura García-González, et al. · Cellular and Molecular Life Sciences · 116
Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease
2013 · Patrizia Giannoni, Florence Gaven, et al. · Frontiers in Aging Neuroscience · 115
PDF
Evidence for Early Cognitive Impairment Related to Frontal Cortex in the 5XFAD Mouse Model of Alzheimer's Disease
2013 · Stéphane D. Girard, Kévin Baranger, et al. · Journal of Alzheimer s Disease · 111
The antibacterial and antifungal properties of trappin‐2 (pre‐elafin) do not depend on its protease inhibitory function
2008 · Kévin Baranger, Marie‐Louise Zani, et al. · FEBS Journal · 110
PDF
Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges
2020 · Pauline Zipfel, Christophe Rochais, et al. · Journal of Medicinal Chemistry · 94
PDF
Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP
2019 · Laura García-González, Dominika Pilat, et al. · Frontiers in Aging Neuroscience · 91
PDF
Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer’s disease: evidence for a pro-amyloidogenic role of MT1-MMP
2014 · Nathalie A. Py, Amandine E. Bonnet, et al. · Frontiers in Aging Neuroscience · 87
PDF
Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer’s disease
2016 · Véréna Landel, Pascal Millet, et al. · Molecular Neurodegeneration · 79
PDF
Chronic treatments with a 5-HT 4 receptor agonist decrease amyloid pathology in the entorhinal cortex and learning and memory deficits in the 5xFAD mouse model of Alzheimer's disease
2017 · Kevin Baranger, Patrizia Giannoni, et al. · Neuropharmacology · 72
Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer’s disease: Alleviation by pantethine
2017 · Manuel van Gijsel-Bonnello, Kévin Baranger, et al. · PLoS ONE · 68
PDF
MT5-MMP Promotes Alzheimer’s Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro
2017 · Kévin Baranger, Amandine E. Bonnet, et al. · Frontiers in Molecular Neuroscience · 58
PDF
Role of Matrix Metalloproteinases in Migration and Neurotrophic Properties of Nasal Olfactory Stem and Ensheathing Cells
2013 · Adlane Ould-Yahoui, Oualid Sbai, et al. · Cell Transplantation · 54
Endogenous and synthetic MMP inhibitors in CNS physiopathology
2014 · Kévin Baranger, Santiago Rivera, et al. · Progress in brain research · 53
Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases
2009 · Marie‐Louise Zani, Kévin Baranger, et al. · Protein Science · 51
PDF
Donecopride, a Swiss army knife with potential against Alzheimer's disease
2019 · Christophe Rochais, Cédric Lecoutey, et al. · British Journal of Pharmacology · 45
SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions
2011 · Marie-Louise Zani, Annabelle Tanga, et al. · Biochemical Society Transactions · 41
Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP‐2 and BACE‐1 activities, and the modulation of APP trafficking
2018 · Jean-Michel Paumier, Nathalie A. Py, et al. · The FASEB Journal · 40
Works count: 91
Citation count: 2,803
H-index: 29
I10-index: 36
Year
Topic
Type